Julie Gerberding, President, Merck Vaccines

Crises, Crossroads, and Credibility

[soundcloud url=”https://api.soundcloud.com/tracks/89335700″ params=”color=ff5500&auto_play=false&hide_related=false&show_comments=true&show_user=true&show_reposts=false” width=”100%” height=”166″ iframe=”true” /]

Julie Gerberding is president of Merck Vaccines. She is responsible for the commercialization of the current portfolio of vaccines, planning for the introduction of vaccines from the company’s vaccine pipeline, and accelerating Merck’s ongoing efforts to broaden access to its vaccines in the developing world. Before joining Merck, Dr. Gerberding led the Centers for Disease Control and Prevention (CDC) as director from 2002 to 2009. In this position, she was responsible for coordinating more than 40 emergency response initiatives for public health crises including anthrax bioterrorism, SARS, avian influenza, and natural disasters. She also advised governments around the world on urgent public health issues such as AIDS, chronic diseases, and obesity.